Sonio is a French health-tech company, founded in 2020 and acquired by Samsung Medison in 2024, that develops AI-powered software designed to enhance the quality, efficiency, and accessibility of prenatal ultrasound screenings and diagnostics. The company aims to improve maternal and child health by providing tools that help clinicians detect congenital malformations, which often go undetected, and standardize ultrasound reporting.